Cargando…
Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity
SIMPLE SUMMARY: Early toxicity of radiotherapy (RT) (from the beginning of treatment to 3 months after its end) may compromise cancer treatments and its prediction is a medical, social and economic challenge. Beyond clinical/dosimetric factors, much of the variation in the risk of toxicity is curren...
Autores principales: | Deneuve, Sophie, Mirjolet, Céline, Bastogne, Thierry, Duclos, Mirlande, Retif, Paul, Zrounba, Philippe, Roux, Pierre-Eric, Poupart, Marc, Vogin, Guillaume, Foray, Nicolas, Pereira, Sandrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160794/ https://www.ncbi.nlm.nih.gov/pubmed/34069662 http://dx.doi.org/10.3390/cancers13102477 |
Ejemplares similares
-
The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review
por: Pereira, Sandrine, et al.
Publicado: (2022) -
Monte Carlo simulations guided by imaging to predict the in vitro ranking of radiosensitizing nanoparticles
por: Retif, Paul, et al.
Publicado: (2016) -
Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule
por: Pêtre, Adeline, et al.
Publicado: (2018) -
Nanoparticles for Radiation Therapy Enhancement: the Key Parameters
por: Retif, Paul, et al.
Publicado: (2015) -
Addictions, Social Deprivation and Cessation Failure in Head and Neck Squamous Cell Carcinoma Survivors
por: Nokovitch, Lara, et al.
Publicado: (2023)